scispace - formally typeset
M

Michele Caraglia

Researcher at Seconda Università degli Studi di Napoli

Publications -  562
Citations -  24508

Michele Caraglia is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Cancer & Cancer cell. The author has an hindex of 67, co-authored 525 publications receiving 20615 citations. Previous affiliations of Michele Caraglia include Temple University & Magna Græcia University.

Papers
More filters
Journal ArticleDOI

Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC

TL;DR: It is shown that the synergistic TIP/DTX combination determines synergistic apoptotic conditions but, at the same time, it modulates the expression of the components of the multichaperone complex that is, in turn, involved in the regulation of the stability of members of the ras‐mediated pathway.
Journal ArticleDOI

The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer.

TL;DR: In this paper, the authors summarize the major upregulated and downregulated miRNAs in colitis-associated colorectal cancer and their roles in genes expression modulation in chronic colonic-inflammation-induced carcinogenesis, including programmed cell-death pathways.
Journal ArticleDOI

Role of perineural invasion as a prognostic factor in laryngeal cancer.

TL;DR: The results of the present study highlighted the importance of performing a closer clinical and instrumental follow-up in patients with laryngeal cancer whose histopathological examination is positive for PNI, and it is important to complement the surgical therapeutic treatment with adjuvant RT.
Journal ArticleDOI

Tumour-specific uptake of anti-cancer drugs: the future is here.

TL;DR: A new avenue in anti-cancer treatment has been disclosed with the use of DDS and the different reasons to encapsulate an anti-tumour drug in DDS including eventual damages induced by their extravasation or by eccipients used to their solubilisation, the rapid break-down of the drug in vivo and the specific bio-distribution of theDrug in tumour tissues.